Dana Barlow, MD - Medicare Emergency Medicine in Big Stone Gap, VA

Dana Barlow, MD is a medicare enrolled "Emergency Medicine" physician in Big Stone Gap, Virginia. His current practice location is 1990 Holton Ave E, Big Stone Gap, Virginia. You can reach out to his office (for appointments etc.) via phone at (276) 523-3111.

Dana Barlow is licensed to practice in Virginia (license number 101041953) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1760424048.

Contact Information

Dana Barlow, MD
1990 Holton Ave E,
Big Stone Gap, VA 24219
(276) 523-3111
Not Available



Physician's Profile

Full NameDana Barlow
GenderMale
SpecialityEmergency Medicine
Location1990 Holton Ave E, Big Stone Gap, Virginia
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1760424048
  • Provider Enumeration Date: 06/12/2006
  • Last Update Date: 08/17/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 4284524380
  • Enrollment ID: I20040319000881

Medical Identifiers

Medical identifiers for Dana Barlow such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1760424048NPI-NPPES
010289769MedicaidVA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 29124 (Kentucky)Secondary
207P00000XEmergency Medicine 101041953 (Virginia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dana Barlow allows following entities to bill medicare on his behalf.
Entity NameYalinie Medics Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1992964944
PECOS PAC ID: 5991938557
Enrollment ID: O20140506000690

News Archive

Communication between bacterial species promotes resistance to antibiotics: Study

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.

New finding sheds light on how HIV eludes treatment by mutating

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells change as they reproduce is key to developing better tests and treatments for patients.

Senate leaders agree on privacy protections amendment to health care information technology bill

Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) on Wednesday announced that sponsors of a bill (HR 1693) that would promote the use of health care information technology have agreed to include an amendment Leahy proposed to help protect patient privacy, CQ HealthBeat reports. Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.) and ranking member Mike Enzi (R-Wyo.) introduced the legislation last October.

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

Read more Medical News

› Verified 7 days ago

Entity NameCorrect Care, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215987441
PECOS PAC ID: 8628980992
Enrollment ID: O20170425001394

News Archive

Communication between bacterial species promotes resistance to antibiotics: Study

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.

New finding sheds light on how HIV eludes treatment by mutating

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells change as they reproduce is key to developing better tests and treatments for patients.

Senate leaders agree on privacy protections amendment to health care information technology bill

Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) on Wednesday announced that sponsors of a bill (HR 1693) that would promote the use of health care information technology have agreed to include an amendment Leahy proposed to help protect patient privacy, CQ HealthBeat reports. Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.) and ranking member Mike Enzi (R-Wyo.) introduced the legislation last October.

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dana Barlow is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dana Barlow, MD
1431 Centerpoint Blvd, Suite 100,
Knoxville, TN 37932-1984

Ph: () -
Dana Barlow, MD
1990 Holton Ave E,
Big Stone Gap, VA 24219

Ph: (276) 523-3111

News Archive

Communication between bacterial species promotes resistance to antibiotics: Study

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.

New finding sheds light on how HIV eludes treatment by mutating

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells change as they reproduce is key to developing better tests and treatments for patients.

Senate leaders agree on privacy protections amendment to health care information technology bill

Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) on Wednesday announced that sponsors of a bill (HR 1693) that would promote the use of health care information technology have agreed to include an amendment Leahy proposed to help protect patient privacy, CQ HealthBeat reports. Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.) and ranking member Mike Enzi (R-Wyo.) introduced the legislation last October.

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

Read more News

› Verified 7 days ago


Emergency Medicine Doctors in Big Stone Gap, VA

Dr. Arthur H Toups, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1990 Holton Ave E, Big Stone Gap, VA 24219
Phone: 276-523-3111    
Sudershan Gupta, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1990 Holton Ave E, Big Stone Gap, VA 24219
Phone: 276-523-8600    
Donald Elmer Dingus, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 205 E 19th St N, Big Stone Gap, VA 24219
Phone: 276-524-4920    Fax: 276-524-1401
Dr. John H Brannum, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1990 Holton Ave E, Big Stone Gap, VA 24219
Phone: 276-523-3111    
Mary E. Duncan, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1990 Holton Ave E, Big Stone Gap, VA 24219
Phone: 276-523-8612    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.